Speakers:
Prof Sir John Burn, Professor of Clinical Genetics, Newcastle University
Prof Timothy Bishop, Professor of Genetic Epidemiology, University of Leeds
A new international study lasting over a decade and involving nearly 1000 patients was published in The Lancet, and was the first study to carry out a randomised controlled trial assessing the effect of aspirin on the incidence of cancer.